Serum HER-2 ECD and the efficacy of letrozole in ER+/ PR+ metastatic breast cancer: Preliminary results of a prospective study

Colomer, R.; Llombart, A.; Ramos, M.; Mayordomo, J. I.; Fernandez, R.; Tusquets, I.; Barnadas, A.; Gil, M.; Carabantes, F.; Baena, J. M.; Ruiz, M.; Palomero, M.; Vera, R.; Munoz, M.; Constenla, M.; Rita, J.; Ojeda, B.; Calvo, L.; Lloveras, B.; Montero, S.; Alba, E.

Links

ORCID

Tools

Export citation

Search in Google Scholar

Serum HER-2 ECD and the efficacy of letrozole in ER+/ PR+ metastatic breast cancer: Preliminary results of a prospective study

Journal article published in 2001 by R. Colomer, A. Llombart, M. Ramos, J. I. Mayordomo, R. Fernandez, I. Tusquets, A. Barnadas, M. Gil, F. Carabantes, J. M. Baena, M. Ruiz, M. Palomero, R. Vera, M. Munoz, M. Constenla and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload